1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The impact of regular, low-dose, sustained-release morphine for chronic breathlessness on caregiver burden : An exploratory analysis of the BEAMS trial
(
- Contribution to journal › Article
- 2020
-
Mark
Regular, sustained-release morphine for chronic breathlessness : A multicentre, double-blind, randomised, placebo-controlled trial
(
- Contribution to journal › Article
-
Mark
Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial
(
- Contribution to journal › Article
-
Mark
Breathlessness, Anxiety, Depression, and Function–The BAD-F Study : A Cross-Sectional and Population Prevalence Study in Adults
(
- Contribution to journal › Article
-
Mark
No excess harms from sustained-release morphine : A randomised placebo-controlled trial in chronic breathlessness
(
- Contribution to journal › Article
-
Mark
Quality of Life Changes With Duration of Chronic Breathlessness : A Random Sample of Community-Dwelling People
(
- Contribution to journal › Article
- 2018
-
Mark
Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
(
- Contribution to journal › Article
- 2017
-
Mark
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness : Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol
(
- Contribution to journal › Article